Fact CheckerSign in

NCT06917833Not yet recruiting

Impact of Maternal Body Mass Index on Infant Hypoxic Events at Time of Delivery ,Cross-sectional Study.

Source: ClinicalTrials.gov · Last updated 9 Apr 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Offspring from overweight or obese mothers appear to be at up to 38% increased risk of being admitted to the neonatal intensive care unit than the offspring of mothers with a normal BMI. In terms of Apgar scores at birth, babies of obese mothers have been reported to have a 31% excess risk of having a low Apgar score (defined at \<7 at 1 minute) . Infants born to obese mothers demonstrate a spectrum of outcomes, suggesting that there is a complex interplay of factors that defines the precise altered metabolic environment to which the fetus is exposed and that determines the risk of complications

Status (registry)
Not yet recruiting
Study type
Observational
Enrollment
544 (estimated)
First submitted
6 Mar 2025
Start date
20 Apr 2025
Primary completion date
28 Jan 2026
Lead sponsor
Ain Shams University
Diseases
Obesity
NCT number
NCT06917833

What you commit to

  • Study type: Observational
  • Planned participants: 544
  • From 20 Apr 2025 to the primary completion date, 28 Jan 2026
  • No sites listed in no country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Scarred uterus (myomectomy, previous cesarean section)

Other illness

  • Any medical disorders that affect neonatal outcomes (diabetes mellitus, hypertension, mixed connective tissue disorders)
  • Condition jeopardizing the maternal or fetal life (for example: antepartum hemorrhage, pathological CTG, cord prolapse)

Other

  • Macrosomic baby\>4 kgs
  • Liquor abnormalities (oligohydramnios or polyhydramnios).
  • Other indications for cesarean sections for example: placenta accreta spectrum
  • Smokers.
  • Any abnormalities in follow up of delivery regarding partogram.

Who the study is looking for

  • Age of 18 - 40 years.
  • Term pregnancy (37 weeks gestation or more)
  • Singleton pregnancy
  • Cephalic presentation at time of delivery
  • In labour

Age in the registry: 18 years to 40 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

This page is information, not medical advice. Discuss any trial with your doctor.